Abstract Submission - Deadline passed, now Closed
Please click on the link below to submit your abstracts for the 21st International Symposium on Pediatric Neuro-Oncology (ISPNO 2024). The submission deadline is on Monday, February 12, 2024, at 11:59 PM ET. Abstracts submitted after the deadline will not be accepted.
All accepted abstracts will be published as submitted in an online supplement to Neuro-Oncology. Edits to abstracts cannot be made after the February 12, 2024, deadline. Abstract submitters should carefully check their abstract for content errors, spelling, names, etc. before submitting. ISPNO neither proofreads nor corrects spelling, typographical, grammatical, or scientific errors.
Once the accepted abstracts are submitted to the journal for publication, requests for withdrawals cannot be processed. All requests to withdraw abstracts MUST be received by Monday, March 11, 2024, at 11:59 PM ET.
All presenters are expected to register for the symposium and must be able to present in person. Pre-recorded or virtual presentation will not be allowed.
Abstract Specifications
Title – 50 word maximum
Abstract – 300 word maximum
Authors – maximum of 75 authors
Institutional Affiliation – maximum of 2 per author
Submission Categories
Atypical Teratoid Rhabdoid Tumor
Biological Correlates, Biomarkers
Cancer Neuroscience
Craniopharyngioma
Diffuse Midline Glioma, Diffuse Intrinsic Pontine Glioma
Diversity, Equity, and Inclusion
Early Phase Clinical Trials/Developmental Therapeutics
Embryonal Tumor with Multilayered Rosettes (ETMR), Other Embryonal Tumors, Rare tumors
Ependymoma
Epidemiology
Genomics, Epigenomics, Metabolomics
Germ Cell Tumors
High Grade Glioma
Imaging
Immune-, Cell-, Gene-, and Viral-Based Therapies
Low Grade Glioma
Medulloblastoma
Neurofibromatosis and other Cancer Predisposition Syndromes
Neuropsychology, Quality of Life, Survivorship
Neurosurgery, Drug Delivery
Nursing, Social Work, Patient Support
Others (not fitting any other category)
Palliative Care
Pathology, Classification
Pediatric Neuro-Oncology in Low/Middle Income Countries
Preclinical Models, Drug Discovery
Radiation Oncology
Tumor Biology, Stem Cells, Models
Late Breaking (Please carefully read the guidelines below before submitting a late breaking abstract)
Click here to submit your abstract or cut and paste this URL into a browser:
Late Breaking Abstract Guidelines
ISPNO recognizes that some rapidly advancing investigations may include results that will not be available at the time of the abstract submission deadline of February 5, 2024. For this reason, ISPNO will allow authors to submit their Late-Breaking research for consideration for ISPNO, however submissions must adhere to guidelines below.
Please note that only a limited number of abstracts from this Late-Breaking category will be selected for oral presentation at the meeting. Authors should note the following important information before submitting a Late-Breaking Abstract:
Late-Breaking abstracts will be considered for oral presentation only.
Late-Breaking abstracts accepted for oral presentation will not be included in the regular abstract supplement to Neuro-Oncology and will be published electronically on the day of presentation.
Late-Breaking abstracts not accepted for presentation will not be considered for any type of presentation format (poster or oral) and will not be part of the meeting program.
Late-Breaking abstracts will not be considered for awards.
This category is not intended to offer a second deadline for regular abstract submissions.
For an abstract to be considered for Late-Breaking Abstract status, the submitting author must:
Select the “Late-Breaking Abstract” category in the abstract submission site.
Submit an abstract, including the objectives and methods but excluding the results and conclusions of the research, by the submission deadline of Monday, February 5, 2024. Include any information that supports the potential for late-breaking impact, and the date of planned analysis for the abstract.
Submit a final Late-Breaking abstract (with updated data) by Monday, April 15, 2024. If an updated abstract is not submitted by that date, the abstract will be automatically rejected.